CoChat
Sign Up
Cited by 4Metabolism and Genetic DisordersLysosomal Storage Disorders ResearchNeurological diseases and metabolism

Leriglitazone: Frustration and hope in adrenoleukodystrophy

Schöls, Ludger·2023·The Lancet Neurology
DOI 10.1016/s1474-4422(22)00518-x
Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(22)00518-x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a larger randomized trial, the decline in walking distance remained comparable in the leriglitazone and placebo groups.

    “In a larger randomized trial, however, the decline in walking distance remained comparable in the leriglitazone and the placebo groups [468,469].”

    From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [469]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schöls, L.
Affiliations
German Center for Neurodegenerative Diseases (DE)
Corresponding author
Schöls, Ludger
ORCID
Schöls, Ludger
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2023-02
Volume
22
Issue
2
Pages
103-105
ISSN
1474-4422 (ISSN-L)
DOI
10.1016/s1474-4422(22)00518-x
OpenAlex
W4317488893
Cited by
4
References
1
Citations by year
2025: 1 · 2024: 1 · 2023: 2
FWCI
0.78
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • DZNE Pub (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
adrenoleukodystrophy, X-linked adrenoleukodystrophy, ABCD1 gene, peroxisomal membrane proteins, very long chain fatty acids, peroxisomal beta-oxidation, adrenal insufficiency, myeloneuropathy, peroxisome biogenesis disorders
MeSH terms
Adrenoleukodystrophy, Frustration, Humans, Thiazolidinediones

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review